Concepedia
Statistics
Publications
1
Citations
254
H-Index
Active since
2024
Affiliations
AstraZeneca (Brazil)(Current)
B. Sangro is an author at AstraZeneca (Brazil).
Publications per year
2024–2024
Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
B. Sangro, Stephen L. Chan, Robin Kate Kelley et al. · Annals of Oncology · 2024 · 254 citations · Full text
1–1 of 1